Suchergebnisse - covid-19

PubPharm (3.955)

1

Dynamics of SARS-CoV-2 antibodies after natural infection : insights from a study on Pasteur Institute of Tunis employees

enthalten in: The Libyan journal of medicine | 2024

von Cherif, I. | Kharroubi, G. | Darragi, I. | +7

2

SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022- and 2023

enthalten in: Emerging infectious diseases | 2024

von Lustig, Y. | Canetti, M. | Indenbaum, V. | +11

3

Intranasal administration of Escherichia coli Nissle expressing the spike protein of SARS-CoV-2 induces long-term immunization and prevents spike protein-mediated lung injury in mice

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2024

von Sarnelli, G. | Del Re, A. | Palenca, I. | +9

4

Interplay of inflammatory markers and anti-SARS-CoV-2 antibodies in COVID-19 mortality : A prospective cohort study

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2024

von Mink, S. | Drexel, H. | Leiherer, A. | +4

5

Tixagevimab/cilgavimab for the prevention of COVID-19 in vaccine-refractory patients with autoimmune diseases : a prospective cohort study

enthalten in: Rheumatology (Oxford, England) | 2024

von Minopoulou, I. | Tascilar, K. | Corte, G. | +12

6

Carrier-free mRNA vaccine induces robust immunity against SARS-CoV-2 in mice and non-human primates without systemic reactogenicity

enthalten in: Molecular therapy : the journal of the American Society of Gene Therapy | 2024

von Abbasi, S. | Matsui-Masai, M. | Yasui, F. | +7

7

The investigation of the dynamics of changes in neutralizing antibody titers against type 5 adenovirus in the context of vaccination against a new coronavirus infection

enthalten in: Virology | 2024

von Amosova, I. | Timoshicheva, T. | Kadyrova, R. | +6

8

Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults : A phase 3, randomized, active-controlled, multicenter trial

enthalten in: Vaccine | 2024

von Nurdin, A. | Movieta Nency, Y. | Maddeppungeng, M. | +24

9

Detection of SARS-CoV-2-specific mucosal antibodies in saliva following concomitant COVID-19 and influenza vaccination in the ComFluCOV trial

enthalten in: Vaccine | 2024

von Baum, H. | Thirard, R. | Halliday, A. | +13

10

Control of complement-induced inflammatory responses to SARS-CoV-2 infection by anti-SARS-CoV-2 antibodies

enthalten in: The EMBO journal | 2024

von Bermejo-Jambrina, M. | van der Donk, L. | van Hamme, J. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[396]